Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective

Summary The cost-effectiveness of bazedoxifene was compared to placebo in France, Germany, Italy, Spain, Sweden and the UK from a healthcare perspective using FRAX® for both fracture risks and for treatment efficacy. Cost/QALY differences were explained to a large extent by differences in fracture r...

Full description

Saved in:
Bibliographic Details
Published in:Osteoporosis international Vol. 22; no. 3; pp. 955 - 965
Main Authors: Borgström, F, Ström, O, Kleman, M, McCloskey, E, Johansson, H, Odén, A, Kanis, J. A
Format: Journal Article
Language:English
Published: London London : Springer-Verlag 01-03-2011
Springer-Verlag
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first